Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in MRNA — Moderna, Inc.

CIK 886982 NEW YORK, NY
Back to MRNA Full portfolio

Position in MRNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$335,467,805
+$218,964,052 QoQ
Shares Held
6,603,697
+67.2% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93.43373870727261.ToString("F0")% Shared 0.ToString("F0")% None 6.566261292727392.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$8,483,600
PutShares
167,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. MRNA ranks #3 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,417,875 $1,079,677,898
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,300,558 $1,004,863,129
3 MRNA
Moderna, Inc.
This page 		6,603,697 $335,467,805
4 ROIV
Roivant Sciences Ltd.
 11,111,591 $307,791,069
5 PRAX
Praxis Precision Medicines, Inc.
 710,734 $228,991,385
6 INCY
Incyte Corp
 2,351,221 $221,296,919
7 RVMD
Revolution Medicines, Inc.
 2,185,500 $212,539,874
8 RYTM
Rhythm Pharmaceuticals, Inc.
 1,965,432 $170,933,620

All Filings in MRNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,483,600 167,000
2026-03-31 $335,467,805 6,603,697
2025-12-31 $430,554 14,600
2025-12-31 $51,498,387 1,746,300
2025-12-31 $116,503,753 3,950,619
2025-09-30 $377,118 14,600
2025-09-30 $82,132,915 3,179,749
2025-06-30 $402,814 14,600
2025-06-30 $93,895,362 3,403,239
2025-03-31 $91,147,970 3,215,096
2025-03-31 $3,529,575 124,500
2024-12-31 $137,286,139 3,301,735
2024-12-31 $5,343,030 128,500
2024-12-31 $2,062,368 49,600
2024-09-30 $10,258,405 153,500
2024-09-30 $225,741,579 3,377,848
2024-09-30 $14,989,969 224,300
2024-06-30 $18,869,375 158,900
2024-06-30 $497,035,011 4,185,558
2024-06-30 $15,021,875 126,500
2024-03-31 $12,787,200 120,000
2024-03-31 $418,771,420 3,929,912
2024-03-31 $11,455,200 107,500
2023-12-31 $452,659,203 4,551,626
2023-12-31 $17,274,465 173,700
2023-12-31 $23,569,650 237,000
2023-09-30 $423,900,815 4,103,987
2023-09-30 $14,398,626 139,400
2023-09-30 $7,168,326 69,400
2023-06-30 $421,803,895 3,471,637
2023-06-30 $18,832,500 155,000
2023-06-30 $10,935,000 90,000
2023-03-31 $13,054,300 85,000
2023-03-31 $469,835,773 3,059,225
2023-03-31 $13,269,312 86,400
2022-12-31 $42,264,586 235,300
2022-12-31 $48,138,160 268,000
2022-12-31 $494,524,752 2,753,172
2022-09-30 $14,343,725 121,300
2022-09-30 $149,289,203 1,262,488
2022-09-30 $14,284,600 120,800
2022-06-30 $395,612,502 2,769,426
2022-06-30 $13,327,905 93,300
2022-06-30 $5,685,430 39,800
2022-03-31 $25,287,768 146,800
2022-03-31 $41,979,762 243,700
2022-03-31 $277,763,220 1,612,465
2021-12-31 $23,442,354 92,300
2021-12-31 $38,909,736 153,200
2021-12-31 $329,815,378 1,298,588

Report a Problem

Category
Description
Email (optional, for follow-up)